What is the expected growth rate of the fetal bovine serum market in 2024-2031?
The fetal bovine serum market is anticipated to reach a CAGR of 5.3% during the forecast period 2024-2031, driven by factors like increasing research activity and demand for cell culture applications.
What are some key players in the global fetal bovine serum market?
Major players include Bovogen, Atlas Biologicals, GE Healthcare, Cytiva, HiMedia Laboratories, Merck KgaA, PAN-Biotech, R&D Systems Inc., Rocky Mountain Biologicals, TCS Biosciences Ltd, and Thermo Fisher Scientific.